Literature DB >> 27511365

Correlation of hepatic fractional extracellular space using gadolinium enhanced MRI with liver stiffness using magnetic resonance elastography.

Michael L Wells1, Michael R Moynagh1, Rickey E Carter2, Robert A Childs1, Cameron E Leitch1, Joel G Fletcher1, Benjamin M Yeh3, Sudhakar K Venkatesh4.   

Abstract

PURPOSE: To compare MR hepatic fractional extracellular space (fECS) to liver stiffness (LS) with magnetic resonance elastography (MRE) for evaluation of liver fibrosis. METHODS AND MATERIALS: 71 consecutive patients with suspected chronic liver disease underwent standard liver MRI with MR elastography and additional delayed Gd-DTPA-enhanced sequences at 5 and 10 min in order to calculate hepatic fECS (%) and LS (kilopascals, kPa). Two radiologists blinded to clinical history examined MR images and calculated fECS and LS in identical locations for every patient. Interobserver agreement was calculated using the intraclass correlation coefficient. Pearson's correlation was calculated for LS and fECS measures, as was the area under the receiver operatic curve (AUROC), sensitivity and specificity of fECS to predict liver stiffness ≥2.93 and ≥5 kPa. The sensitivity of fECS for detecting fibrosis was separately analyzed in the subgroup of patients without anatomic findings of cirrhosis.
RESULTS: Substantial to excellent interobserver agreement for both LS and fECS measurements was seen with intraclass correlation of 0.88 (95% CI 0.81-0.92) for LS, 0.77 (95% CI 0.66-0.85) for fECS5 and 0.76 (95% CI 0.64-0.84) for fECS10. A significant correlation was found between MRE and fECS5 (r = 0.47, p < 0.0001) and fECS10 (r = 0.44, p < 0.0001). The performance of fECS improved for detection of advanced fibrosis (≥5 kPa) with AUROC, sensitivity and specificity of 0.72, 38%, and 94% for fECS5 and 0.72, 67%, and 66% for fECS10.
CONCLUSION: fECS correlates modestly with MRE-determined LS. fECS at MRI is a simple calculation to perform and may represent a practical way to suggest the presence of fibrosis during routine liver evaluation.

Entities:  

Keywords:  Fractional extracellular space; Gadolinium; Hepatic extracellular space; Hepatic fibrosis; Liver fibrosis; Liver stiffness; MR elastography; MRI

Mesh:

Substances:

Year:  2017        PMID: 27511365      PMCID: PMC5292879          DOI: 10.1007/s00261-016-0867-8

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  32 in total

1.  Sources of variability in histological scoring of chronic viral hepatitis.

Authors:  Marie-Christine Rousselet; Sophie Michalak; Florence Dupré; Anne Croué; Pierre Bedossa; Jean-Paul Saint-André; Paul Calès
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

2.  Liver MRI and histological correlates in chronic liver disease on multiphase gadolinium-enhanced 3D gradient echo imaging.

Authors:  Diego R Martin; Thomas Lauenstein; Bobby Kalb; Christina Lurie; Hiroumi Kitajima; Puneet Sharma; Khalil Salman; Roger Moreira; Alton B Farris; James Spivey; Enrique Martinez; Steve Hanish; Volkan Adsay
Journal:  J Magn Reson Imaging       Date:  2012-05-07       Impact factor: 4.813

3.  Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.

Authors:  Diego A Aguirre; Cynthia A Behling; Elliot Alpert; Tarek I Hassanein; Claude B Sirlin
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

4.  Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis.

Authors:  Rahul Rustogi; Jeanne Horowitz; Carla Harmath; Yi Wang; Hamid Chalian; Daniel R Ganger; Zongming E Chen; Bradley D Bolster; Saurabh Shah; Frank H Miller
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

Review 5.  Reversibility of hepatitis B virus cirrhosis after therapy: who and why?

Authors:  Pierre Bedossa
Journal:  Liver Int       Date:  2015-01       Impact factor: 5.828

6.  Mechanism of late gadolinium enhancement in patients with acute myocardial infarction.

Authors:  Christoph Klein; Thaiz R Schmal; Stephan G Nekolla; Bernhard Schnackenburg; Eckart Fleck; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2007       Impact factor: 5.364

Review 7.  The global impact of hepatic fibrosis and end-stage liver disease.

Authors:  Young-Suk Lim; W Ray Kim
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

8.  Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity.

Authors:  Maurice H Zissen; Zhen Jane Wang; Judy Yee; Rizwan Aslam; Alexander Monto; Benjamin M Yeh
Journal:  AJR Am J Roentgenol       Date:  2013-12       Impact factor: 3.959

9.  An elevated arterial enhancement fraction is associated with clinical and imaging indices of liver fibrosis and cirrhosis.

Authors:  David Bonekamp; Susanne Bonekamp; Bernhard Geiger; Ihab R Kamel
Journal:  J Comput Assist Tomogr       Date:  2012 Nov-Dec       Impact factor: 1.826

10.  Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: initial validation by comparison with histopathologic sampling.

Authors:  Steve Bandula; Shonit Punwani; William M Rosenberg; Rajiv Jalan; Andrew R Hall; Amar Dhillon; James C Moon; Stuart A Taylor
Journal:  Radiology       Date:  2014-12-08       Impact factor: 11.105

View more
  1 in total

Review 1.  Imaging of Hepatic Fibrosis.

Authors:  Rishi Philip Mathew; Sudhakar Kundapur Venkatesh
Journal:  Curr Gastroenterol Rep       Date:  2018-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.